← Leaderboards
Simon Harding
Visionquest Biomedical, Llc
$1,499,305
Attributed
$4,497,916
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2016–21$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,497,916 · 1
By mechanism
R44$4,497,916 · 1
Top collaborators
- Vinayak S Joshi6 shared
- Susan Lewallen6 shared
Most similar at Visionquest Biomedical, Llc
Same institution · by research overlap
- Vinayak S Joshi$5,519,258
- Peter N Soliz$11,719,733
- Susan Lewallen$1,749,162
- Wendall C Bauman$1,477,351
- Eduardo Simon Barriga$713,113
Others in their field
Top investigators on “Image Analysis”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$98,245,959
- Peter J O'Dwyer · University Of Pennsylvania$86,533,459
- Mark H Ellisman · University Of California, San Diego$77,061,746
- Paul S. Aisen · Cognition Therapeutics, Inc.$76,045,409
Research focus
Image AnalysisInnovationDevicesEnrollmentImproved OutcomeAfricaData SetDetectionDiagnosisDiagnostic AccuracyAlgorithmsDesignCerebral MalariaChildAfrican5 Year OldClinical ResearchBaseAffectDiabetic RetinopathyDiagnosticComputer SoftwareCostInsight
Grant awards (6)
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$1,000,000
R44 · FY2021 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$1,000,000
R44 · FY2020 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$587,952
R44 · FY2019 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$412,048
R44 · FY2019 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$676,207
R44 · FY2017 · AI
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria$821,709
R44 · FY2016 · AI